Exchange Traded Concepts, LLC Biogen Inc. Transaction History

Exchange Traded Concepts, LLC

$4.18 Billion
Q3 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 1,662 shares of BIIB stock, worth $288,838. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,662

Previous 36 4516.67%

Holding current value

$288,838

Previous $8,000 3925.0%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$189.07 - $236.8 $307,427 - $385,036	1,626 Added 4516.67%	1,662 $322,000
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $48,392 - $60,126	-254 Reduced 87.59%	36 $8,000
Q1 2024 Apr 15, 2024	BUY	$212.02 - $267.71 $59,789 - $75,494	282 Added 3525.0%	290 $62,000
Q4 2023 Jan 05, 2024	SELL	$222.59 - $267.94 $890 - $1,071	-4 Reduced 33.33%	8 $2,000
Q3 2023 Oct 18, 2023	BUY	$253.3 - $285.89 $1,013 - $1,143	4 Added 50.0%	12 $3,000
Q2 2023 Jul 20, 2023	SELL	$275.25 - $318.06 $275 - $318	-1 Reduced 11.11%	8 $2,000
Q1 2023 Apr 12, 2023	SELL	$256.56 - $292.34 $2.67 Million - $3.04 Million	-10,398 Reduced 99.91%	9 $2,000
Q4 2022 Jan 17, 2023	BUY	$252.44 - $306.72 $2.54 Million - $3.08 Million	10,048 Added 2798.89%	10,407 $2.88 Million
Q3 2022 Oct 07, 2022	BUY	$194.69 - $268.46 $22,973 - $31,678	118 Added 48.96%	359 $96,000
Q2 2022 Jul 20, 2022	BUY	$187.54 - $223.02 $24,192 - $28,769	129 Added 115.18%	241 $49,000
Q1 2022 Apr 26, 2022	SELL	$193.77 - $244.14 $4.44 Million - $5.59 Million	-22,905 Reduced 99.51%	112 $24,000
Q4 2021 Jan 13, 2022	BUY	$223.92 - $287.77 $1.59 Million - $2.05 Million	7,117 Added 44.76%	23,017 $5.52 Million
Q3 2021 Oct 18, 2021	BUY	$282.99 - $369.05 $4.38 Million - $5.71 Million	15,471 Added 3606.29%	15,900 $4.5 Million
Q2 2021 Jul 30, 2021	BUY	$259.0 - $414.71 $5,698 - $9,123	22 Added 5.41%	429 $149,000
Q1 2021 Apr 20, 2021	SELL	$242.95 - $284.63 $8.59 Million - $10.1 Million	-35,372 Reduced 98.86%	407 $114,000
Q4 2020 Jan 19, 2021	SELL	$236.26 - $355.63 $2.54 Million - $3.83 Million	-10,767 Reduced 23.13%	35,779 $8.76 Million
Q3 2020 Oct 30, 2020	BUY	$264.77 - $305.71 $3.02 Million - $3.49 Million	11,419 Added 32.51%	46,546 $13.2 Million
Q2 2020 Jul 15, 2020	BUY	$258.66 - $342.55 $7.84 Million - $10.4 Million	30,295 Added 626.97%	35,127 $9.4 Million
Q1 2020 Apr 14, 2020	BUY	$268.85 - $341.04 $1.28 Million - $1.62 Million	4,755 Added 6175.32%	4,832 $1.53 Million
Q4 2019 Jan 22, 2020	BUY	$220.06 - $304.07 $16,944 - $23,413	77 New	77 $23,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Biogen Inc. Transaction History